Globus Medical (GMED) PT Raised to $93 at Barclays
Tweet
Share
E-mailGet Alerts GMED Hot Sheet
Price: $85.67 +0.61%
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Rating Summary:
22 Buy, 8 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 12 | Down: 19 | New: 8
Join SI Premium – FREE
Barclays analyst Matt Miksic raised the price target on Globus Medical (NYSE: GMED) to $93.00 (from $85.00) while maintaining a Overweight rating.
You May Also Be Interested In
- Monopar Therapeutics (MNPR) PT Raised to $133 at BTIG
- Lemon Tree Hotels (LEMONTRE:IN) PT Raised to INR180 at Macquarie
- MYR Group (MYRG) PT Lowered to $422 at Goldman Sachs
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
